Overweight , Obesity: Clinical Trials

11 trials for Overweight , Obesity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 active not recruiting, 3 completed, 2 not yet recruiting, 2 recruiting. 11 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 211Active not recruiting 4, Completed 3, Not yet recruiting 2, Recruiting 2
Phase 11Not yet recruiting 1
Phase 31Recruiting 1

Follow Overweight , Obesity: new trials by email Literature Review of Overweight , Obesity trials Research Report on Overweight , Obesity

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Safety and Efficacy of Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity
ecnoglutide tablet, placebo with matching dosage - Overweight , Obesity, Weight Management
Phase 2Not yet recruitingHangzhou Sciwind Biosciences Co., Ltd.1802026-11-102026-11-10
Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity.
Semaglutide, Placebo - Type 1 Diabetes, Overweight , Obesity
Phase 2 / Phase 3RecruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre402026-10-132026-10-23
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
ALV-100, Placebo - Overweight , Obesity, Adults
Phase 2RecruitingAlveus Therapeutics, Inc.2202026-08-102026-10-26
A Study of SRSD384 in Overweight or Obese Participants
SRSD384 injection, Placebo - Overweight , Obesity
Phase 1 / Phase 2Not yet recruitingSirius Therapeutics Co., Ltd.782026-06-012026-06-05
Phase 2 Study of MWN109 Tablet for Weight-Loss Maintenance in Participants With Overweight or Obesity
MWN109 1, MWN109 2 - Overweight , Obesity
Phase 2Active not recruitingShanghai Minwei Biotechnology Co., Ltd712026-03-022026-09-04
Phase 2 Study of MWN109 Tablet in Participants With Overweight or Obesity
MWN109 1, MWN109 2, MWN109 3 - Overweight , Obesity
Phase 2CompletedShanghai Minwei Biotechnology Co., Ltd2552026-01-052026-08-28
Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight
MWN109 1, MWN109 2, MWN109 3 - Overweight , Obesity
Phase 2Active not recruitingShanghai Minwei Biotechnology Co., Ltd1252025-12-262026-08-28
Efficacy and Safety of ZT006 in Overweight and Obese Participants
ZT006, Placebo of ZT006 - Overweight , Obesity
Phase 2Active not recruitingBeijing QL Biopharmaceutical Co.,Ltd1842025-12-122026-06-12
Phase 2 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity
MWN105 1, MWN105 2, MWN105 3 - Overweight , Obesity
Phase 2CompletedShanghai Minwei Biotechnology Co., Ltd1202025-09-032026-09-04
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight or Obesity
MWN109 1, MWN109 2, MWN109 3 - Overweight , Obesity
Phase 2CompletedShanghai Minwei Biotechnology Co., Ltd1202025-08-232026-08-28
Study on the Efficacy of Probiotics in the Treatment of Childhood Obesity and Their Effects on Gut Microbiota
Probiotic, Placebo - Overweight , Obesity
Phase 2Active not recruitingMin-Tze LIONG602023-12-012026-03-04

Narrower conditions

Obesity (11)  ·  Overweight (11)  ·  Diabetes Mellitus, Type 1 (1)

Broader conditions

Body Weight (11)  ·  Nutrition Disorders (11)  ·  Nutritional and Metabolic Diseases (11)  ·  Overnutrition (11)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Signs and Symptoms (11)  ·  Autoimmune Diseases (1)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Immune System Diseases (1)  ·  Metabolic Diseases (1)

Interventions

Probiotics (1)  ·  Saline Solution (1)  ·  semaglutide (1)

Sponsors

Shanghai Minwei Biotechnology Co., Ltd (5)  ·  Alveus Therapeutics, Inc. (1)  ·  Beijing QL Biopharmaceutical Co.,Ltd (1)  ·  Hangzhou Sciwind Biosciences Co., Ltd. (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  Min-Tze LIONG (1)  ·  Sirius Therapeutics Co., Ltd. (1)

Countries

China (8)  ·  Australia (1)  ·  Canada (1)  ·  Malaysia (1)  ·  United States (1)

Top investigators

Aihua Zhang, MD. (1)  ·  Hongwei Jiang (1)  ·  Linong Ji, MD (1)  ·  Melissa-Rosina Pasqua, MD, PhD (1)